drugset / Trial / NCT05191290
Comparison of Biocompatibility of Plasmapheresis Procedures With Citrate and Heparin Anticoagulation
RandomizedCrossoverOpen-labelTreatment
Summary
Membrane plasmapheresis is one of the methods for treating immune diseases. Plasmapheresis removes autoantibodies and immune complexes, paraproteins, lipoproteins and reduces the concentration of cytokines. In membrane plasmapheresis, plasma is separated from blood cells by a highly permeable membrane. The filtered plasma is then discarded and replaced with replacement fluid. During the procedure, there is an activation of the coagulation system, because of the extracorporeal blood circulation. The anticoagulation during the procedure is therefore necessary.
Timeline
- Start
- 2022-01-21
- Primary completion
- 2022-12-30
- Completion
- 2022-12-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Heparin | Other / unclassified | 2000 iu | Intravenous |
| Subject | sodium citrate | Unknown | 27 mmol | Intravenous |
Indications
No indication recorded.